Loading…
Based on limited metadata without access to the full letter text, the FDA issued a warning to LifeHealth Science on May 15, 2020 regarding drug products. While the specific nature of the violations cannot be determined from the available metadata, the letter indicates regulatory concerns within the drug manufacturing or distribution sector. Additional details about the specific violations, issuing office, and remedial actions required would require review of the complete warning letter.